Full Length Research Paper
References
Bédié YVB, Yapo-Kee B, Ecrabey YC, Lohore C, Vanie Bi F, Agnero GG, Cisse-Camara, Monde AA, Yavo DT (2023). Clinical and biological profile of patients admitted for diabetic ketoacidosis in the University Teaching Hospital of Cocody (Abidjan). Health Sciences and Disease 24(4):4. | ||||
Behan KJ, Mbizo J, Johnston MA (2015). Is the Correlation of HbA1c to average Glucose Predictable in Individuals with Sickle Cell Trait? Journal of Diabetes Science and Technology 10(1):236 237. Crossref |
||||
Bleyer AJ, Reddy SV, Sujata L, Russell GB, Akinnifesi D, Bleyer Jr AJ, Hire D, Shihabi Z, Knovich MA, Daeihagh P, Calles J (2010). Sickle Cell Trait and Development of Microvascular Complications in Diabetes Mellitus. Clinical Journal of the American Society of Nephrology 5(6):1015 1020. Crossref |
||||
Gariani KI, Hagon-Traub I, Philippe J (2009). Diabète de type 1 ou 2 ? ou autre ? Revue Médicale Suisse 5:1248-1253. Crossref |
||||
Hirst JA, McLellan JH, Price CP, English E, Feakins BG, Stevens RJ, Farmer AJ (2017). Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis. Clinical Chemistry and Laboratory Medicine 55(2):167-180. Crossref |
||||
Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A (2004). IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clinical Chemistry 50(1):166-174. Crossref |
||||
International Diabetes Federation (2015). IDF Diabetes Atlas, 7th edition. Brussels, Belgium: International Diabetes Federation. | ||||
Kabytaev K, Connolly S, Rohlfing CL, Sacks DB, Stoyanov AV, Little RR (2016). Higher degree of glycation of hemoglobin S compared to hemoglobin A measured by mass spectrometry: Potential impact on HbA1c testing. Clinica Chimica Acta 458:40 43. Crossref |
||||
Kakou-Danho B, Atiméré YN, Koné D, Akroman M, Boka A, Diakité L (2020). Prévalence des hémoglobinopathies au laboratoire central du CHU de Treichville à Abidjan [Prevalence of Hemoglobinopathies at the Central Laboratory of Treichville Teaching Hospital in Abidjan]. Revue Internationale des Sciences Médicales d'Abidjan, 22(3):2010-2015. | ||||
Lacy ME, Wellenius GA, Sumner AE, Correa A, Carnethon MR, Liem RI, Wilson JG, Sacks DB, Jacobs DR, Carson AP, Luo X, Gjelsvik A, Reiner AP, Naik RP, Liu S, Musani SK, Eaton CB, Wu WC (2017). Association of Sickle Cell Trait with Hemoglobin A1c in African Americans. Journal of the American Medical Association 317(5):507 515. Crossref |
||||
Lenters-Westra E, English E (2018). Evaluation of Four HbA1c Point-of-Care Devices Using International Quality Targets: Are They Fit for the Purpose? Journal of Diabetes Science and Technology 12(4):762-770. Crossref |
||||
Lara A (2017). Drépanocytose chez les afro-américains: peut-on se fier à l'HbA1c pour évaluer la glycémie? Univadis. la glycémie? [Internet]. Paris: Univadis; 2017 [Consulté le 3/11/2021]. Disponible sur: |
||||
Little RR, Roberts WL (2009). A Review of Variant Hemoglobin is Interfering with Hemoglobin A1c Measurement. Journal of diabetes science and technology 3(3):446-451. Crossref |
||||
Little RR, La'ulu SL, Hanson SE, Rohlfing CL, Schmidt RL (2015). Effects of 49 Different Rare Hb Variants on HbA1c Measurement in Eight Methods. Journal of Diabetes Science and Technology 9(4):849?856. Crossref |
||||
Monde AA, Camara-Cissé M, Koffi KG, Diallo I, Ake AA, Yapo-Ake B, Ecrabey YC, Kouakou F, Bene Yao RE, Tiahou G (2020). Correlation between glycated hemoglobin and venous blood sugar in diabetic patients monitored in Abidjan. African Journal of Biochemistry Research 14(4):135-141. Crossref |
||||
Sumner AE, Thoreson CK, O'Connor MY, Ricks M., Chung ST, Tulloch-Reid MK, Lozier JN, Sacks DB (2015). Detection of Abnormal Glucose Tolerance in Africans Is improved by Combining A1C With Fasting Glucose: The Africans in America Study. Diabetes Care 38(2): 213 219. Crossref |
||||
Schwartz D (1996). Méthodes statistiques à l'usage des médecins et biologistes [Internet]. 4? Éd. Paris : Publications Médecine Sciences; 1993 [Consulté le 11/09/2021]: |
||||
Tavares RS, Souza FO, Francescantonio IC, Soares WC, Mesquita MM (2017). HbA1c levels in individuals heterozygous for hemoglobin variants. Revista da Associação Médica Brasileira 63(4):341 346. Crossref |
||||
Wang SH, Wang, TF, Wu CH, Chen SH (2014). In-Depth Comparative Characterization of Hemoglobin Glycation in Normal and Diabetic Bloods by LC-MSMS. Journal of the American Society for Mass Spectrometry 25(5):758 766. Crossref |
||||
World Health Organization (WHO) (2006). Management of birth defects and haemoglobin disorders: Report of a joint WHO-March of Dimes meeting. Geneva, Switzerland: World Health Organization. https://apps.who.int/iris/handle/10665/43587 | ||||
World Health Organization (WHO) (2024). Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. World Health Organization. 89 p. |
||||
Yapo AE, Assayi M, Aka NB (1990). Les valeurs de référence de 21 constituants biochimiques sanguins de l'ivoirien adulte présumé. Pub Med Africaine 11:49-57. |
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0